Browse Category

NYSE:HCA 1 November 2025 - 12 February 2026

HCA Healthcare stock stays firm after-hours after a sharp run — here’s what traders watch next

HCA Healthcare stock stays firm after-hours after a sharp run — here’s what traders watch next

HCA Healthcare shares rose 0.7% to $535.22 in after-hours trading Thursday after hitting a high of $552.85 earlier in the day. The move follows a 5.86% jump Wednesday to a record close after HCA’s 2026 profit outlook topped estimates and the company announced a $10 billion buyback. A shareholder filed to sell 8,020 shares worth about $4.1 million. Investors await Friday’s U.S. CPI report.
12 February 2026
HCA Healthcare stock slides as traders digest $10B buyback, 2026 outlook and ACA headwinds

HCA Healthcare stock slides as traders digest $10B buyback, 2026 outlook and ACA headwinds

HCA Healthcare shares fell 2.8% to $491.72 Wednesday, erasing some of Tuesday’s 11% rally after earnings. The company set 2026 EPS guidance at $29.10–$31.50 and announced a $10 billion share buyback. Investors weighed cost cuts against risks from changes in ACA coverage and payer mix. Fourth-quarter revenue rose 6.7% to $19.51 billion, with net income up 30.6% to $1.88 billion.
28 January 2026
HCA stock jumps after earnings and a $10B buyback — what to watch before Wednesday’s open

HCA stock jumps after earnings and a $10B buyback — what to watch before Wednesday’s open

HCA Healthcare shares surged 7.1% to $505.84 after the company raised its 2026 profit outlook and approved a new $10 billion share buyback. Fourth-quarter revenue rose 6.7% to $19.51 billion, with net income at $1.88 billion. Investors remain cautious as ACA exchange subsidies expire, potentially reducing patient volumes. The board also declared a $0.78 quarterly dividend, payable March 31.
HCA Healthcare stock jumps on upbeat 2026 outlook, $10B buyback as ACA subsidy cliff looms

HCA Healthcare stock jumps on upbeat 2026 outlook, $10B buyback as ACA subsidy cliff looms

HCA Healthcare shares jumped 7.4% to $507.50 Tuesday after the company raised its 2026 profit outlook and announced a $10 billion share buyback. Fourth-quarter revenue rose 6.7% to $19.51 billion, with adjusted earnings at $8.01 per share. HCA expects 2026 revenue between $76.5 billion and $80 billion, and earnings per share of $29.10 to $31.50. The board approved a quarterly dividend of $0.78 per share, payable March 31.
27 January 2026
HCA Healthcare (HCA) Stock After Hours on Dec. 24, 2025: What Happened After the Bell and What to Know Before Markets Reopen

HCA Healthcare (HCA) Stock After Hours on Dec. 24, 2025: What Happened After the Bell and What to Know Before Markets Reopen

HCA Healthcare closed at $474.06 in a shortened Christmas Eve session, then slipped to $468.74 in after-hours trading, down 1.12%. Trading volume was about 250,000 shares, well below normal. U.S. stock markets will remain closed for Christmas Day and reopen Friday, Dec. 26, 2025. Policy uncertainty over ACA premium subsidies continues to weigh on the healthcare sector.
25 December 2025
HCA Stock Outlook: HCA Healthcare (NYSE: HCA) Ends the Week Near $485 After a Volatile Swing — Latest News, Forecasts, and the Week Ahead (Updated Dec. 12, 2025)

HCA Stock Outlook: HCA Healthcare (NYSE: HCA) Ends the Week Near $485 After a Volatile Swing — Latest News, Forecasts, and the Week Ahead (Updated Dec. 12, 2025)

HCA Healthcare shares closed at $484.77 on Friday, ending the week nearly unchanged after a sharp 4% drop Wednesday on heavy volume. The midweek decline followed reports of possible Medicare reimbursement cuts under discussion in Congress. HCA remains below its late-November record high of $515.85. Trading volatility this week drew renewed focus to policy risk for hospital operators.
13 December 2025
HCA Healthcare Stock Near Record Highs: December 2025 Earnings, Forecasts and Policy Risks Explained

HCA Healthcare Stock Near Record Highs: December 2025 Earnings, Forecasts and Policy Risks Explained

HCA Healthcare stock closed near $503 on December 2, 2025, up over 38% from its July peak, following record Q3 results and raised guidance. Q3 revenue rose 9.6% to $19.2 billion, with net income up 29% to $1.64 billion. The company repurchased 6.5 million shares in Q3 and maintained a quarterly dividend of $0.72 per share. Market cap stands around $117 billion.
HCA Healthcare (HCA) Stock on December 1, 2025: Near All‑Time Highs, Upgraded Guidance and What Comes Next

HCA Healthcare (HCA) Stock on December 1, 2025: Near All‑Time Highs, Upgraded Guidance and What Comes Next

HCA Healthcare closed at about $503 on December 1, down 1% from Friday and just below its record high of $520 set in the prior session. Institutional investors shifted positions, with Dixon Mitchell raising its stake by 6.9% and others reducing holdings. The stock is up 71.5% year-to-date and trades at a discount to sector averages. Institutional holders control about 62.7% of shares.
1 December 2025
Tech Turmoil: iPhone 17 Stuns, Starlink Outage, Cyber Hacks & Chip Wars – Non-AI News Roundup (Sept 14–15, 2025)

AI Frenzy Unleashed: Nvidia Rockets to $5T, Google’s Gemini Enterprise Debuts, and Global AI Battles Heat Up

Nvidia became the world’s first $5 trillion company as demand for its AI chips soared. Microsoft and OpenAI reset their partnership, with OpenAI set to buy $250 billion more in Azure services and Microsoft dropping its right of first refusal. Google launched Gemini Enterprise for business AI, while Meta and Alphabet sharply increased AI spending. Intel is in talks to acquire SambaNova, and the US Energy Department partnered with AMD to build two new AI supercomputers.
Go toTop